-
US mulls lifting sanctions on Iranian oil at sea despite war on Tehran
-
IMF raises concern over global inflation, output over Iran war
-
Middle East war weighs on global trade outlook: WTO
-
Cunningham out for NBA Pistons with collapsed lung
-
Belarus frees 250 political prisoners in US-brokered deal
-
Iran attacks on gas and oil refineries heighten fears over war fallout
-
Fernandez 'completely committed' to Chelsea insists Rosenior
-
Call to add Nazi camps to UNESCO list
-
England cricket chiefs to front up to media over Ashes flop
-
'Miracle': Europe reconnects with lost spacecraft
-
Nigeria 'challenged by terrorism', president says on UK state visit
-
Woltemade deployed too deep to be dangerous at Newcastle, says Nagelsmann
-
Wimbledon expansion plan gets legal boost
-
EU summit fails to rally Orban behind stalled Ukraine loan
-
New Morocco coach praises 'well-deserved' Cup of Nations decision
-
Senegal to appeal CAF Africa Cup of Nations decision
-
'Mixing things up': Nagelsmann goes for flexibility in new Germany squad
-
Record-setter Hodgkinson hopes 'fourth time lucky' at world indoors
-
Atletico target Romero says his focus on Spurs' survival bid
-
Karalis hits prime form to threaten Duplantis surprise
-
Freshly returned Mbappe leads France squad for Brazil, Colombia friendlies
-
US earns its lowest-ever score on freedom index
-
Europe's super elite teach English clubs a Champions League lesson
-
What we know about the UK's deadly meningitis outbreak
-
Karl handed Germany debut as Musiala misses out with injury
-
What cargo ships are passing Hormuz strait?
-
Bank of England holds interest rate amid Middle East war
-
Energy prices soar, Iran and US trade threats after Qatar gas hit
-
'Surreal' for F1 world champion Norris to have Tussauds waxwork
-
Iran hangs three men in first executions over January protests
-
North Korea, Philippines qualify for 2027 Women's World Cup
-
Man Utd boss Carrick expects hard test against resolute Bournemouth
-
Oil prices surge, stocks sink on energy shock fears
-
Alibaba pins hopes on AI as quarterly net profit drops
-
Oil soars 10% after Qatar energy sites hit in Mideast war
-
Defiant Orban digs in over blocked Ukraine loan at EU talks
-
Iran 'boycotting' USA but not World Cup: football federation chief
-
Tokyo's dazzling cherry blossom season officially begins
-
Energy prices surge, stocks sink amid rising energy shock fears
-
Iran causes 'extensive' damage to Qatar gas hub, sparks Trump warning
-
Baby monkey Punch acclimatising, making new friends at Japan zoo
-
Labubu creators hope for monster film hit in Sony co-production
-
Kings of K-pop: What to know about BTS's comeback
-
Patching the wounds of Kinshasa's street children
-
Thailand's Anutin: Millionaire PM with a populist approach
-
In Seoul square of protest and history, BTS fans welcome grand comeback
-
Hong Kong panel hears safety measures failed on day of deadly fire
-
Trump threatens to destroy Iran's largest gas field
-
Doncic and James power Lakers over Rockets as win streak hits seven
-
Inter continue Serie A title hunt ahead of Italy's date with World Cup destiny
California start-up sends tiny robots on voyage into brains
Sending miniature robots deep inside the human skull to treat brain disorders has long been the stuff of science fiction -- but it could soon become reality, according to a California start-up.
Bionaut Labs plans its first clinical trials on humans in just two years for its tiny injectable robots, which can be carefully guided through the brain using magnets.
"The idea of the micro robot came about way before I was born," said co-founder and CEO Michael Shpigelmacher.
"One of the most famous examples is a book by Isaac Asimov and a film called 'Fantastic Voyage,' where a crew of scientists goes inside a miniaturized spaceship into the brain, to treat a blood clot."
Just as cellphones now contain extremely powerful components that are smaller than a grain of rice, the tech behind micro-robots "that used to be science fiction in the 1950s and 60s" is now "science fact," said Shpigelmacher.
"We want to take that old idea and turn it into reality," the 53-year-old scientist told AFP during a tour of his company's Los Angeles research and development center.
Working with Germany's prestigious Max Planck research institutes, Bionaut Labs settled on using magnetic energy to propel the robots -- rather than optical or ultrasonic techniques -- because it does not harm the human body.
Magnetic coils placed outside the patient's skull are linked up to a computer that can remotely and delicately maneuver the micro-robot into the affected part of the brain, before removing it via the same route.
The entire apparatus is easily transportable, unlike an MRI, and uses 10 to 100 times less electricity.
- 'You're stuck' -
In a simulation watched by AFP, the robot -- a metal cylinder just a few millimeters long, in the shape of a tiny bullet -- slowly follows a pre-programed trajectory through a gel-filled container, which emulates the density of the human brain.
Once it nears a pouch filled with blue liquid, the robot is swiftly propelled like a rocket and pierces the sack with its pointed end, allowing liquid to flow out.
Inventors hope to use the robot to pierce fluid-filled cysts within the brain when clinical trials begin in two years.
If successful, the process could be used to treat Dandy-Walker Syndrome, a rare brain malformation affecting children.
Sufferers of the congenital ailment can experience cysts the size of a golf ball, which swell and increase pressure on the brain, triggering a host of dangerous neurological conditions.
Bionaut Labs has already tested its robots on large animals such as sheep and pigs, and "the data shows that the technology is safe for us" human beings, said Shpigelmacher.
If approved, the robots could offer key advantages over existing treatments for brain disorders.
"Today, most brain surgery and brain intervention is limited to straight lines -- if you don't have a straight line to the target, you're stuck, you're not going to get there," said Shpigelmacher.
Micro-robotic tech "allows you to reach targets you were not able to reach, and reaching them repeatedly in the safest trajectory possible," he added.
- 'Heating up' -
The US Food and Drug Administration (FDA) last year granted Bionaut Labs approvals that pave the way for clinical trials to treat Dandy-Walker Syndrome, as well as malignant gliomas -- cancerous brain tumors often considered to be inoperable.
In the latter case, the micro-robots will be used to inject anti-cancer drugs directly into brain tumors in a "surgical strike."
Existing treatment methods involve bombarding the whole body with drugs, leading to potential severe side effects and loss of effectiveness, said Shpigelmacher.
The micro-robots can also take measurements and collect tissue samples while inside the brain.
Bionaut Labs -- which has around 30 employees -- has held discussions with partners for the use of its tech to treat other conditions affecting the brain including Parkinson's, epilepsy or strokes.
"To the best of my knowledge, we are the first commercial effort" to design a product of this type with "a clear path to the clinic trials," said Shpigelmacher.
"But I don't think that we will be the only one... This area is heating up."
O.Lorenz--BTB